# EMERPHED
> **NDA213407** · New Drug Application · Sponsor: NEXUS · Approved 2020-04-17
## Drug
- **FDA Application Number:** NDA213407
- **Application type:** New Drug Application
- **Brand name:** EMERPHED
- **Generic name:** EPHEDRINE SULFATE
- **Active ingredients:** EPHEDRINE SULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** NEXUS
- **Manufacturer:** Nexus Pharamaceuticals Inc.
- **First approval:** 2020-04-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213407)
---
*MORVS · CC0 1.0*